M&A Deal Summary

Weigao Group Acquires Argon Medical Devices

On January 1, 2018, Weigao Group acquired medical products company Argon Medical Devices from RoundTable Healthcare Management

Acquisition Highlights
  • This is Weigao Group’s 1st transaction in the Medical Products sector.
  • This is Weigao Group’s 1st transaction in the United States.
  • This is Weigao Group’s 1st transaction in Texas.

M&A Deal Summary
Date 2018-01-01
Target Argon Medical Devices
Sector Medical Products
Buyer(s) Weigao Group
Sellers(s) RoundTable Healthcare Management
Deal Type Add-on Acquisition

Target

Argon Medical Devices

Plano, Texas, United States
Argon Medical Devices, Inc. is a manufacturer and supplier of specialty single-use vascular interventional and pressure monitoring devices utilized in the cardiology, radiology and critical care market segments. Argon Medical Devices was founded in 1972 and is based in Plano, Texas.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Weigao Group

Weihai, China
Category Company
Founded 2000
Sector Medical Products
Employees12,519
Revenue 13.2B CNY (2023)
DESCRIPTION

Weigao Group is a provider in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. Weigao Group was founded in 2000 and is based in Weihai, China.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Texas) 1 of 1
Country (United States) 1 of 1
Year (2018) 1 of 1

Seller(S) 1

SELLER

RoundTable Healthcare Management

Lake Forest, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 2.9B USD
Size Large
Type Sector Focused
DESCRIPTION

RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.

DEAL STATS #
Overall 15 of 22
Sector (Medical Products) 10 of 13
Type (Add-on Acquisition) 12 of 14
State (Texas) 1 of 3
Country (United States) 14 of 21
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-20 Deerland Probiotics & Enzymes

Kennesaw, Georgia, United States

Deerland Probiotics & Enzymes is a developer, formulator, and manufacturer of enzyme- and probiotic-based dietary supplements. Deerland specializes in customized product formulations and offers a line of clinically-studied branded ingredients, including its probiotic, DE111, which recently earned Non-GMO Project verification and Health Canada approval. The Company also offers multiple branded enzymes, including its innovative Glutalytic and ProHydrolase products. Deerland Enzymes was founded in 1990 and is based in Kennesaw, Georgia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-01 Advantice Health

Cedar Knolls, New Jersey, United States

Advantice Health consists of market-leading therapeutic health & wellness brands that are primarily in the skincare, footcare and first aid product categories. The Company’s branded products lead with efficacy and science, and are sold through an assortment of brick-and-mortar and e-commerce retailers across North America. Advantice Health is based in Cedar Knolls, New Jersey.

Buy -
Mergr

Product

Company

Legal